1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East and Africa Next-generation Antibody Market – By Therapeutic Area

1.3.2        Middle East and Africa Next-generation Antibody Market – By Technology

1.3.3        Middle East and Africa Next-generation Antibody Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Next-generation Antibody Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East and Africa PEST Analysis

4.3         Experts Opinion

5.           Next-generation Antibody Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Growing Demand for Next-Generation Antibody Therapeutics

5.2         Market Restraints

5.2.1        Complications Associated with Manufacturing and Approvals

5.3         Market Opportunities

5.3.1        Proliferation of Biotechnology Industry in Developing Regions

5.4         Future Trends

5.4.1        Developments in Next-Generation Antibodies

5.5         Impact Analysis

6.           Next-generation Antibody Market – Middle East and Africa Analysis

6.1         Middle East and Africa Next-generation Antibody Market Revenue Forecast and Analysis

7.           Middle East and Africa Next-generation Antibody Market Revenue and Forecasts To 2028– by Therapeutic Area

7.1         Overview

7.2         Middle East and Africa Next-generation Antibody Market, By Therapeutic Area, 2021 & 2028 (%)

7.3         Oncology

7.3.1        Overview

7.3.2        Oncology: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

7.4         Autoimmune or Inflammatory

7.4.1        Overview

7.4.2        Autoimmune or Inflammatory: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

8.           Middle East and Africa Next-generation Antibody Market Revenue and Forecasts To 2028 – Technology

8.1         Overview

8.2         Middle East and Africa Next-generation Antibody Market Share by Segment - 2021 & 2028 (%)

8.3         Antibody-drug conjugates

8.3.1        Overview

8.3.2        Antibody-drug conjugates: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.4         Bispecific antibodies

8.4.1        Overview

8.4.2        Bispecific antibodies: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.5         Fc engineered antibodies

8.5.1        Overview

8.5.2        Fc engineered antibodies: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.6         Antibody fragments and antibody-like proteins

8.6.1        Overview

8.6.2        Antibody fragments and antibody-like proteins: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

8.7         Biosimilar antibody products

8.7.1        Overview

8.7.2        Biosimilar antibody products: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)

9.           Next-generation Antibody Market Revenue and Forecasts to 2028 – Middle East & Africa Analysis

9.1         Middle East & Africa Next-generation Antibody Market Revenue and Forecasts To 2028

9.1.1        Overview

9.1.2        Middle East & Africa Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.3        Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.1.4        Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

9.1.5        Middle East & Africa Next-generation Antibody Market Revenue and Forecasts to 2028, By Country (%)

9.1.5.1          UAE: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.1.1          Overview

9.1.5.1.2          UAE: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.1.3          UAE: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.1.5.1.4          UAE: Next-generation Antibody Market Revenue and Forecasts To 2028, By Technology (US$ Million)

9.1.5.2          Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.2.1          Overview

9.1.5.2.2          Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.2.3          Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.1.5.2.4          Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts To 2028, By Technology (US$ Million)

9.1.5.3          South Africa: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.3.1          Overview

9.1.5.3.2          South Africa Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.3.3          South Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.1.5.3.4          South Africa: Next-generation Antibody Market Revenue and Forecasts To 2028, By Technology (US$ Million)

9.1.5.4          Rest of Middle East and Africa: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.4.1          Overview

9.1.5.4.2          Rest of Middle East and Africa: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

9.1.5.4.3          Rest of Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

9.1.5.4.4          Rest of Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts To 2028, By Technology (US$ Million)

10.        Impact of COVID-19 Pandemic on Next-generation Antibody Market

10.1      Middle East and Africa: Impact Assessment of COVID-19 Pandemic

11.        Next-generation Antibody Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      F. HOFFMANN-LA ROCHE LTD.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Kyowa Kirin Co., Ltd.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Takeda Pharmaceutical Company Limited

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Amgen Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Pfizer Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Catalent Inc

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      AstraZeneca

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             New Cancer Cases Registered Worldwide, 2020

Table 2.             Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million).

Table 3.             Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 4.             UAE: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 5.             UAE: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 6.             Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 7.             Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 8.             South Africa Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 9.             South Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 10.          Rest of Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Therapeutic Area (US$ Million)

Table 11.          Rest of Middle East & Africa: Next-generation Antibody Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 12.          Organic Developments in the Next-generation Antibody Market

Table 13.          Inorganic Developments in the Next-generation Antibody Market

Table 14.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Next-generation Antibody Market Segmentation

Figure 2.           Next-generation Antibody Market, By Country

Figure 3.           Middle East and Africa Next-generation Antibody Market Overview

Figure 4.           Oncology Segment Held Largest Share of Therapeutic Area Segment in Next-generation Antibody Market

Figure 6.           Middle East and Africa Next-generation Antibody Market- Leading Country Markets (US$ Million)

Figure 7.           Middle East and Africa: PEST Analysis

Figure 8.           Experts Opinion

Figure 9.           Next-Generation Antibody Market Impact Analysis of Driver and Restraints

Figure 10.        Middle East and Africa Next-generation Antibody Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 11.        Middle East and Africa Next-generation Antibody Market, by Therapeutic Area, 2021 & 2028 (%)

Figure 12.        Oncology: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Autoimmune or Inflammatory: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Middle East and Africa Next-generation Antibody Market Share by Segment - 2021 & 2028 (%)

Figure 15.        Antibody-drug conjugates: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 16.        Bispecific antibodies: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 17.        Fc engineered antibodies: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 18.        Antibody fragments and antibody-like proteins: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 19.        Biosimilar antibody products: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)

Figure 20.        Middle East & Africa Next-generation Antibody Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 21.        Middle East & Africa Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Middle East & Africa Next-generation Antibody Market Revenue and Forecasts to 2028, By Country (%)

Figure 23.        UAE: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Saudi Arabia: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        South Africa: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        Rest of Middle East and Africa: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        Impact of COVID-19 Pandemic in Middle East and Africa Country Markets